Skip to main content

Advertisement

Table 3 Albuminuria in relation to age, sociodemographic, blood pressure and biochemical data among Type 1 and Type 2 patients

From: Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania

  Type 1 diabetes N = (91) Type 2 diabetes N = (153)
  NORMAL (N = 79) (AER ≤20 ug/min) ABNORMAL (N = 12) (AER > 20 ug/min) NORMAL (N = 127) (AER ≤20 ug/min) ABNORMAL (N = 26) (AER > 20 ug/min)
Age at inclusion (yrs) ‡ 20.0 (4–44.8) 21.5 (11–38) 51.6 (23.5–85) 54(36.6–80)
Duration of diabetes (yrs) ‡ 3.0 (0–17) 4.2 (0–9) 3 (0–25) 7.5(o.2–24)***
BMI (kg/m2) (mean ± SD) # 19.3 ± 3.7 18.8 ± 4.4 27.9 ± 5 27 ± 4.7
SBP mmHg ‡ 109 (72–140) 108 (90–140) 130(90–210) 160 (110–200)***
DBP mmHg ‡ 72 (50–110) 80 (54–100) 82(52–120) 92 (70–136)***
AER (ug/min) ‡ 4.9 (0.65–19.9) 51 (22.7–290.2)*** 4.67 (1.29–18.92) 164.6 (22.1–2000)***
Creatinine clearance (mls/min) ‡ 129(46–481) 132(96.4–191) 107(40–273) 86.6(40–178.5)
HbA1c (%) ‡ 13.5(6.3–>14) 14(8.9–>14) 9.6(4.4–>14) 10.1(5.4–>14)
Proportion anti HT medication N(%)‡‡ 0 0 31(24) 15(58)**
Proportion with Hypertension N(%)‡‡ 7(9.7) 2 (18.2) 59(47.6) 21(80.8)**
  1. Data expressed as median (min-max) unless stated otherwise.
  2. ‡ Mann Whitney test, # unpaired t test, ‡‡ Fischer's exact test
  3. p value – *p < 0.05, **p < 0.01, ***p < 0.001